Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT between MERCK & CO., INC. and...Exclusive Research Collaboration, License and Commercialization Agreement • August 11th, 2008 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
Contract Type FiledAugust 11th, 2008 Company Industry JurisdictionThis EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT (this "Agreement") is effective as of June 21, 2004, (the "Effective Date") and is entered into by and between Merck & Co., Inc., a New Jersey corporation ("Merck"), and Vertex Pharmaceuticals Incorporated, a Massachusetts corporation ("Vertex").
EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT between MERCK & CO., INC. and VERTEX PHARMACEUTICALS INCORPORATED Portions of this exhibit, indicated by the mark “[***],” have been redacted pursuant to a confidential...Exclusive Research Collaboration, License and Commercialization Agreement • September 7th, 2012 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
Contract Type FiledSeptember 7th, 2012 Company Industry JurisdictionThis EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is effective as of June 21, 2004, (the “Effective Date”) and is entered into by and between Merck & Co., Inc., a New Jersey corporation (“Merck”), and Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (“Vertex”).
Attn: Office of Business Development Re: Exclusive Research Collaboration, License and Commercialization Agreement (as amended by that certain letter agreement, dated February 4, 2005, and as may be subsequently amended, the “Agreement”), effective as...Exclusive Research Collaboration, License and Commercialization Agreement • August 9th, 2006 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations
Contract Type FiledAugust 9th, 2006 Company IndustryThis Letter (this “Letter”) will confirm the understanding of Merck and Vertex regarding the extension of the Agreement’s Research Program Term and is intended to be legally binding on both Parties. Capitalized terms used but not otherwise defined in this Letter shall have the meanings provided in the Agreement.
Confidential Treatment Requested. Confidential portions of this document have been redacted and have been separately filed with the Commission EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT between MERCK & CO., INC. and...Exclusive Research Collaboration, License and Commercialization Agreement • July 2nd, 2004 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations • New York
Contract Type FiledJuly 2nd, 2004 Company Industry JurisdictionThis EXCLUSIVE RESEARCH COLLABORATION, LICENSE AND COMMERCIALIZATION AGREEMENT (this “Agreement”) is effective as of June 21, 2004, (the “Effective Date”) and is entered into by and between Merck & Co., Inc., a New Jersey corporation (“Merck”), and Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (“Vertex”).